Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)

In today's trading, Briacell Therapeutics Corp opened at $1.04 and closed at $1.05. It traded at a low of $1.03 to a high of $1.05.

Shares shrank -2.78% from the previous day's close of $1.08.

During the day across North America, the TSX Composite closed 0.91% at 22814.81, the S&P 500 closed -0.51% at 5399.22, the Dow Jones Industrial Average closed 0.20% at 39935.07 and the Nasdaq Composite closed -0.93% at 17181.72.

Briacell Therapeutics Corp traded under BCT on the Toronto Stock Exchange (TSX).

Trading volume was 1,605 on 7 total trades, with an average volume of 35,019 over 5 days.

Trading across the entire TSX saw 3,857 price advancers against 1,325 declines and 128 unchanged.

During the prior 52 weeks, BCT.TO has traded as high as $10.29 (August 28,2023) and low as $0.84 (July 24,2024). Moreover, in the last 52 weeks, Briacell Therapeutics Corp's shares have shrunken -86.88%, while in 2024, they have plummeted -86.54%.

Following today's trading, Briacell Therapeutics Corp has a market capitalization of $19.75 million on a float of 18,285 shares outstanding. Its annual EPS is $-0.37.

Briacell Therapeutics Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Briacell Therapeutics Corp's consensus rating is "Strong Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..